InsideArbitrage Event Driven Monitor – January 20, 2026
Note: You can click on any section title to jump straight to the related tool or page. Merger Arbitrage RAPT: The acquisition of RAPT Therapeutics, Inc. (RAPT) by GSK plc (GSK)…
Written byAsif SuriaSource: InsideArbitrage
Note: You can click on any section title to jump straight to the related tool or page. Merger Arbitrage RAPT: The acquisition of RAPT Therapeutics, Inc. (RAPT) by GSK plc (GSK) for a closing value of $1.9 billion. GSK will pay RAPT Therapeutics shareholders $58 per share, representing a 65.24% premium from the stock’s last close.